within Pharmacolibrary.Drugs.N_NervousSystem.N01B_AnestheticsLocal.N01BB09_Ropivacaine;

model Ropivacaine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 6.449999999999999e-06,
    adminDuration = 600,
    adminMass = 50 / 1000000,
    adminCount = 1,
    Vd = 0.041,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.094,
    k12 = 8.983333333333333e-06,
    k21 = 8.983333333333333e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Ropivacaine</td></tr><tr><td>ATC code:</td><td>N01BB09</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>50</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>41</td><td>L</td></tr>
    <tr><td>clearance:</td><td>387</td><td>ml/min</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Ropivacaine is a long-acting local anesthetic of the amide type, mainly used for surgical anesthesia, postoperative pain management, and acute pain control (e.g., epidural, nerve block, infiltration). It is approved and widely used globally due to its lower cardiotoxicity compared to bupivacaine.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported from adult healthy volunteers following intravenous administration.</p><h4>References</h4><ol><li><p>Borsuk, A, et al., &amp; Wiczling, P (2017). Flip-Flop Phenomenon in Epidural Sufentanil Pharmacokinetics: A Population Study in Children and Infants. <i>Journal of clinical pharmacology</i> 57(9) 1194–1206. DOI:<a href=\"https://doi.org/10.1002/jcph.912\">10.1002/jcph.912</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28510304/\">https://pubmed.ncbi.nlm.nih.gov/28510304</a></p></li><li><p>Olofsen, E, et al., &amp; Dahan, A (2008). Population pharmacokinetic-pharmacodynamic modeling of epidural anesthesia. <i>Anesthesiology</i> 109(4) 664–674. DOI:<a href=\"https://doi.org/10.1097/01.anes.0000334302.50559.c9\">10.1097/01.anes.0000334302.50559.c9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18813046/\">https://pubmed.ncbi.nlm.nih.gov/18813046</a></p></li><li><p>Mossetti, V, et al., &amp; Ivani, G (2012). Local anesthetis and adjuvants in pediatric regional anesthesia. <i>Current drug targets</i> 13(7) 952–960. DOI:<a href=\"https://doi.org/10.2174/138945012800675713\">10.2174/138945012800675713</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22512395/\">https://pubmed.ncbi.nlm.nih.gov/22512395</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.N.N01BB09 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Ropivacaine;
